News for 'drug quality'

What made Pankaj Tripathi Cry

What made Pankaj Tripathi Cry

Rediff.com30 Jul 2021

'Never had I imagined even in my wildest dreams that this 18-year-journey through 80 films would bring me so much love, respect and appreciation.' 'I never thought I would become such a charchit abhineta (popular actor).'

How we can DEFEAT COVID-19

How we can DEFEAT COVID-19

Rediff.com17 Mar 2021

'If people are not cooperating and do not follow policies laid down by the government or follow scientific infection control management, then all will be lost.'

Soldiers' rights more important than those of terrorists: MoS

Soldiers' rights more important than those of terrorists: MoS

Rediff.com23 Aug 2019

Singh said the nation and the society as a whole are gradually getting conditioned to look at things in the eye instead of getting confused by duplicities.

Mankind plans to open US plant, invest Rs 300 crore

Mankind plans to open US plant, invest Rs 300 crore

Rediff.com21 Jan 2016

Mankind has presence in Sri Lanka, Myanmar, Cambodia, Kenya, Uganda, Zambia and Tanzania.

US court rejects Ranbaxy' plea to block launch by rival cos

US court rejects Ranbaxy' plea to block launch by rival cos

Rediff.com20 Nov 2014

US District Judge Beryl Howell in Minneapolis denied Ranbaxy's request, the court filing showed.

No sabotage at Toansa plant, says Ranbaxy

No sabotage at Toansa plant, says Ranbaxy

Rediff.com12 Feb 2014

Company is among the few companies in the sector getting pulled up by FDA for violations at its factories in India.

US authorises Moderna vaccine for emergency use

US authorises Moderna vaccine for emergency use

Rediff.com19 Dec 2020

According to an official statement, the FDA has determined that the Moderna COVID-19 vaccine has met the statutory criteria for issuance of an emergency use authorisation (EUA).

Barty, Serena lead field at Australian Open warm-ups

Barty, Serena lead field at Australian Open warm-ups

Rediff.com7 Jan 2021

On the men's side, the fields have already been divided into two ATP 250 tournaments.

Alkem fudged trial data: German regulator

Alkem fudged trial data: German regulator

Rediff.com16 Apr 2016

The European Medicines Agency's review is the second setback to Alkem Laboratories

Ranbaxy business to be profitable in short term: Sun Pharma

Ranbaxy business to be profitable in short term: Sun Pharma

Rediff.com7 Apr 2014

Sun Pharmaceutical Industries Ltd Chairman Dilip Shanghvi said he expects Ranbaxy Laboratories Ltd to become profitable in the short term.

USFDA issues warning against Cadila Pharmaceuticals

USFDA issues warning against Cadila Pharmaceuticals

Rediff.com12 Nov 2014

The FDA issued the letter on October 15, and has given the company 15 days to respond.

My Top Stock Picks for 2021

My Top Stock Picks for 2021

Rediff.com5 Jan 2021

Three stockmarket experts give their best picks for the New Year.

Dr Reddy's gets warning from US health regulator

Dr Reddy's gets warning from US health regulator

Rediff.com7 Nov 2015

Dr Reddy's gets warning from US health regulator

'Delhi Crime's Emmy puts us on the global map'

'Delhi Crime's Emmy puts us on the global map'

Rediff.com27 Nov 2020

'It is a big historical moment for Indian content.'

What the Economic Survey says

What the Economic Survey says

Rediff.com4 Jul 2019

India needs to sustain a GDP growth rate of 8 per cent to become a five trillion dollar economy by 2025, the Economic Survey has stated.

Not having sex? The problem is curable

Not having sex? The problem is curable

Rediff.com7 Aug 2017

Yet only a few people discuss their sexual problems with their doctors.

How 'Shorty' executed his stunning jailbreak

How 'Shorty' executed his stunning jailbreak

Rediff.com16 Jul 2015

Rediff.com takes a look at the marvel of engineering, criminal ingenuity and dauntless malefaction with which 'El Chapo' escaped from his confinement.

Covid-19 pandemic is boom time for the 'faraway doctor'

Covid-19 pandemic is boom time for the 'faraway doctor'

Rediff.com19 Aug 2020

Tele/video-consults have been effective for patients requiring post-hospitalisation follow-up, especially if they are from outside the city; patients with chronic diseases that need periodic monitoring; and pregnant women who require routine checkup with minimum exposure.

Suspected human hair in tablet cited in Ranbaxy ban

Suspected human hair in tablet cited in Ranbaxy ban

Rediff.com18 Sep 2013

Ranbaxy, which is 63.5 per cent-owned by Japan's Daiichi Sankyo Co and gets more than 40 per cent of its sales from the United States, did not immediately respond to a request on Wednesday for comment on the FDA observations.

Biden unveils health team; names Vivek Murthy as surgeon general

Biden unveils health team; names Vivek Murthy as surgeon general

Rediff.com7 Dec 2020

Dr Anthony Fauci has been named as Chief Medical Adviser to the President on COVID-19, while Dr Rochelle Walensky has been named as Director of the Centers for Disease Control and Prevention; and Dr. Marcella Nunez-Smith as COVID-19 Equity Task Force Chair.

3 Indian pharma firms named in US Congress price probe

3 Indian pharma firms named in US Congress price probe

Rediff.com9 Oct 2014

Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months

What does India export the most to China?

What does India export the most to China?

Rediff.com14 Jul 2020

Though the government has been pushing for exports of high-value manufactured goods across major markets in place of raw materials and input goods, India's top exports to China remain in the raw materials category.

Christmas rave party busted near Delhi; 50 held

Christmas rave party busted near Delhi; 50 held

Rediff.com25 Dec 2014

Seven people have been arrested after anti-narcotics sleuths and Haryana police busted a suspected Christmas-eve rave party being held at a farmhouse in Mewat district on the outskirts of Delhi.

Ranbaxy hires BCG, Mercer for internal strategic project

Ranbaxy hires BCG, Mercer for internal strategic project

Rediff.com1 Jun 2013

Consultants are working with various teams on manufacturing, R&D, etc, to assess per-month productivity of each department.

Punjab polls: AAP promises 25 lakh jobs, free Wi-Fi hotspots in villages

Punjab polls: AAP promises 25 lakh jobs, free Wi-Fi hotspots in villages

Rediff.com4 Jul 2016

Delhi Chief Minister and AAP National Convener Arvind Kejriwal unveiled the party's manifesto for the youth. The party, which is aiming to capture power in the state, will come out with separate manifestos for different sections of society.

Don't worry about H1N1 vaccines: WHO

Don't worry about H1N1 vaccines: WHO

Rediff.com17 Aug 2009

WHO says the regulatory procedures in place for the licencing of pandemic vaccines, including procedures for expediting regulatory approval, are rigorous and do not compromise safety or quality.

How Patanjali is triggering a battle of brands

How Patanjali is triggering a battle of brands

Rediff.com9 Feb 2016

Patanjali continues to take its peers head on.

'India can cut nearly 50% of its imports from China'

'India can cut nearly 50% of its imports from China'

Rediff.com24 Jul 2020

'India has the potential to reduce its trade deficit with China by $8.4 billion in FY21.'

Pfizer set to buy Allergan for more than $150 bn

Pfizer set to buy Allergan for more than $150 bn

Rediff.com23 Nov 2015

The deal would involve Pfizer paying with 11.3 of its shares for each Allergan share.

Govt mulls stringent norms for human trials

Govt mulls stringent norms for human trials

Rediff.com12 Sep 2008

The regulator, which is planning to allow first phase of human clinical trials soon, will make registration of clinical research organisations and ongoing clinical trials mandatory.

Indians far from achieving herd immunity against COVID-19: Vardhan

Indians far from achieving herd immunity against COVID-19: Vardhan

Rediff.com27 Sep 2020

Vardhan said the ICMR is actively researching on reports of COVID-19 reinfection and although the number of such cases is negligible at this moment, the government is fully seized of the importance of the matter, the health ministry said in a statement.

Thriving in the downturn

Thriving in the downturn

Rediff.com6 Apr 2009

These small-scale entrepreneurs offer luxury goods and services that eager customers are still willing to pay for.

WHO refuses vaccine approval

WHO refuses vaccine approval

Rediff.com18 Sep 2008

Companies like Shanta Biotech, Panacea Biotec and Serum Institute of India are among the leading vaccine makers which have not been able to file any fresh application to the WHO due to this temporary de-recognition of the country's drug regulatory system. The WHO pre-qualification is essential for companies to supply vaccines to national immunisation programmes funded by the WHO or UNICEF outside the country.

When did vying for attention become so evil?

When did vying for attention become so evil?

Rediff.com31 Oct 2020

The Social Dilemma shows how social media is turning human beings into lab rats and zombies, notes Chintan Girish Modi.

Trump again calls coronavirus as 'China Virus'

Trump again calls coronavirus as 'China Virus'

Rediff.com25 Aug 2020

In March, he had said that China is responsible for the spread of the novel coronavirus and called the COVID-19 as the "Chinese Virus".

Pfizer says its Covid vaccine is 95% effective in final trials

Pfizer says its Covid vaccine is 95% effective in final trials

Rediff.com18 Nov 2020

Pfizer and BioNTech said they have concluded phase 3 study of their mRNA-based COVID-19 vaccine candidate BNT162b2, meeting all primary efficacy endpoints.

Tap global healthcare marts: Kalam to India Inc

Tap global healthcare marts: Kalam to India Inc

Rediff.com29 Jun 2007

President A P J Abdul Kalam asked the Indian companies on Friday to tap the vast potential for health care products in the international market by maintaining competitive pricing and high quality.

Maharashtra's charge of vaccine shortage 'utterly baseless': Vardhan

Maharashtra's charge of vaccine shortage 'utterly baseless': Vardhan

Rediff.com7 Apr 2021

'The state government is putting Maharashtrians in danger by letting people escape institutional quarantine mandate for the sake of their personal vasuli'

India's Feluda COVID test cheaper alternative to RT-PCR, say scientists

India's Feluda COVID test cheaper alternative to RT-PCR, say scientists

Rediff.com28 Sep 2020

Named after Satyajit Ray's famed detective, the Feluda test, which is priced at Rs 500 and can deliver a result in 45 minutes, is able to differentiate SARS-CoV-2 from other coronaviruses even if genetic variations between them are minute.

US FDA India head quits; regulator goes for rejig

US FDA India head quits; regulator goes for rejig

Rediff.com21 Jul 2014

Altaf Ahmed Lal, country head of the US Food and Drug Administration (US FDA) in India, has quit and so have a few other key officials at the American drug regulator's India office.